Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Cash (2016 - 2025)

Sunshine Biopharma (SBFM) has disclosed Change in Cash for 14 consecutive years, with -$770560.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Cash fell 950.21% year-over-year to -$770560.0, compared with a TTM value of -$2.4 million through Sep 2025, up 64.57%, and an annual FY2024 reading of -$5.6 million, up 7.38% over the prior year.
  • Change in Cash was -$770560.0 for Q3 2025 at Sunshine Biopharma, down from $1.8 million in the prior quarter.
  • Across five years, Change in Cash topped out at $28.5 million in Q2 2022 and bottomed at -$19.0 million in Q4 2022.
  • Average Change in Cash over 5 years is $454076.6, with a median of -$335777.0 recorded in 2021.
  • The sharpest move saw Change in Cash skyrocketed 41959.55% in 2022, then crashed 25270.25% in 2024.
  • Year by year, Change in Cash stood at -$335777.0 in 2021, then tumbled by 5547.28% to -$19.0 million in 2022, then skyrocketed by 84.23% to -$3.0 million in 2023, then soared by 36.95% to -$1.9 million in 2024, then skyrocketed by 59.12% to -$770560.0 in 2025.
  • Business Quant data shows Change in Cash for SBFM at -$770560.0 in Q3 2025, $1.8 million in Q2 2025, and -$1.6 million in Q1 2025.